South Korea's Penetrium Bioscience unveiled a novel approach to cancer treatment that targets the environments surrounding ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will participate in RedChip’s upcoming ...
Takara Bio USA, Inc. today announced a benchmark study comparing the performance of its Trekker® FX technology against ...
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will present at the Internation ...
Enables Whole-Transcriptome In Situ Spatial Biology with Single-Cell Sensitivity at ScaleDebuts at AACR Annual Meeting 2026 ...
RareCyte®, a leader in precision biology products and technologies, today announced a significant expansion of its spatial proteomics portfolio with the commercial launch of the Oriontm HT and Oriontm ...
Discusses Intracranial Activity of a New Therapy in Small Cell Lung Cancer With Brain Metastases April 20, 2026 8:30 AM ...
Ankyra Therapeutics, a clinical-stage biotechnology company pioneering anchored immunotherapy to deliver better outcomes for people with cancer and other serious diseases, announced two poster ...
Technion researchers part of international study that validates fast, accessible alternative to genomic tests using routine ...
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results